ATE433461T1 - Rana pipiens proteine und deren verwendung in der behandlung von tumoren - Google Patents

Rana pipiens proteine und deren verwendung in der behandlung von tumoren

Info

Publication number
ATE433461T1
ATE433461T1 AT99968949T AT99968949T ATE433461T1 AT E433461 T1 ATE433461 T1 AT E433461T1 AT 99968949 T AT99968949 T AT 99968949T AT 99968949 T AT99968949 T AT 99968949T AT E433461 T1 ATE433461 T1 AT E433461T1
Authority
AT
Austria
Prior art keywords
proteins
rana
pipien
tumors
treatment
Prior art date
Application number
AT99968949T
Other languages
English (en)
Inventor
Wojciech Ardelt
Original Assignee
Alfacell Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfacell Corp filed Critical Alfacell Corp
Application granted granted Critical
Publication of ATE433461T1 publication Critical patent/ATE433461T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/463—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from amphibians
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT99968949T 1998-12-30 1999-12-24 Rana pipiens proteine und deren verwendung in der behandlung von tumoren ATE433461T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/223,118 US6239257B1 (en) 1998-12-30 1998-12-30 Family of proteins belonging to the pancreatic ribonuclease a superfamily
PCT/US1999/030799 WO2000040608A1 (en) 1998-12-30 1999-12-24 Proteins from rana pipiens and their use in the treatment of tumors

Publications (1)

Publication Number Publication Date
ATE433461T1 true ATE433461T1 (de) 2009-06-15

Family

ID=22835123

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99968949T ATE433461T1 (de) 1998-12-30 1999-12-24 Rana pipiens proteine und deren verwendung in der behandlung von tumoren

Country Status (6)

Country Link
US (1) US6239257B1 (de)
EP (1) EP1141004B1 (de)
JP (1) JP4516216B2 (de)
AT (1) ATE433461T1 (de)
DE (1) DE69940980D1 (de)
WO (1) WO2000040608A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7229824B2 (en) * 2003-07-17 2007-06-12 Alfacell Corporation Ribonucleases and methods of making them recombinantly
US7655757B2 (en) 2005-06-16 2010-02-02 Wisconsin Alumni Research Foundation Cytotoxic ribonuclease variants
EP1910541B1 (de) 2005-06-16 2010-10-20 Wisconsin Alumni Research Foundation Zytotoxische ribonukleasevarianten
CN100372869C (zh) * 2006-04-18 2008-03-05 河北师范大学 棕点湍蛙抗微生物多肽及其在制药中的应用
BR112012010202A2 (pt) 2009-11-02 2015-09-22 Univ Washington molécula de nuclease hibrida polipeptideo dimerico, composição farmacêutica molécula de acido nucleico vetor de expressão recombinante célula hospedeira transformada metodo para preparar a molécula de nuclease e metodo para tratar ou previnir uma condição associada com uma imune anormal
PL2704737T3 (pl) 2011-04-29 2018-07-31 University Of Washington Terapeutyczne kompozycje nukleaz i sposoby
US10988745B2 (en) 2013-10-31 2021-04-27 Resolve Therapeutics, Llc Therapeutic nuclease-albumin fusions and methods
JP2017512837A (ja) 2014-03-28 2017-05-25 タミール バイオテクノロジー，インコーポレイテッド ウイルス感染の治療または予防における使用のためのｒｎアーゼ
US9919034B2 (en) 2014-03-28 2018-03-20 Tamir Biotechnology, Inc. Methods of treating and prophylactically protecting mammalian patients infected by viruses classified in Baltimore group V
US9642794B2 (en) 2014-08-18 2017-05-09 Tamir Biotechnology, Inc. Antiviral pharmaceutical for topical administration
US10835598B2 (en) 2014-08-18 2020-11-17 Orgenesis Inc. Prophylactic protection against viral infections, particularly HIV
SG10201911292SA (en) 2015-06-15 2020-02-27 Tamir Biotechnology Inc Pharmaceuticals for treatment of viral infections of the eye
CA2999514A1 (en) 2015-09-25 2017-03-30 Okogen, Inc. Viral conjunctivitis treatment using ranpirnase and/or amphinase
WO2017142807A1 (en) 2016-02-16 2017-08-24 Tamir Biotechnology, Inc. Treatment or prevention of zika virus infections by administration of a ribonuclease
EP3490587B1 (de) 2016-07-26 2021-06-16 Squiquera, Luis Prophylaktischer schutz vor virusinfektionen
US11331378B2 (en) 2016-07-26 2022-05-17 Orgenesis Inc. Prophylactic protection against viral infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4882421A (en) * 1982-09-23 1989-11-21 Alfacell Corporation Pharmaceutical for treating tumors and method for making it
US5728805A (en) * 1988-04-06 1998-03-17 Alfacell Corp. Pharmaceuticals and method for making them
US5559212A (en) * 1988-04-06 1996-09-24 Alfacell Corporation Frog embryo and egg-derived tumor cell anti-proliferation protein
JP2972334B2 (ja) * 1989-11-13 1999-11-08 アルフアセル・コーポレイシヨン 精製された蛋白質および生物活性治療薬
ATE281528T1 (de) * 1996-02-21 2004-11-15 Us Gov Health & Human Serv Rekombinante ribonuklease proteine

Also Published As

Publication number Publication date
WO2000040608A1 (en) 2000-07-13
JP2002534075A (ja) 2002-10-15
EP1141004A1 (de) 2001-10-10
US6239257B1 (en) 2001-05-29
DE69940980D1 (de) 2009-07-23
EP1141004B1 (de) 2009-06-10
JP4516216B2 (ja) 2010-08-04

Similar Documents

Publication Publication Date Title
ATE433461T1 (de) Rana pipiens proteine und deren verwendung in der behandlung von tumoren
ATE349428T1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
BR9811956B1 (pt) naftiridinonas e composição farmacêutica compreendendo as mesmas.
ATE198050T1 (de) Therapeutische anwendungen von bpi-protein- produkten zur behandlung von humaner meningococcämia
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
ES2155817T1 (es) Inhibicion de la actividad de la quinasa p38 utilizando ureas heterociclicas sustituidas con arilo y heteroarilo.
ATE362766T1 (de) Apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dislipidemischer erkrankungen
ES2154253T1 (es) Inhibicion de la actividad de la quinasa p38 utilizando ureas heterociclicas sustituidas.
ATE222769T1 (de) Verabreichung von gm-csf zur behandlung der gehirntumoren und verhütung deren wiederauftretens
DE69631478D1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
ATE311853T1 (de) Verwendung von krillenzymen zur behandlung von zahnbelag
ATE273031T1 (de) Aminobiguanide und ihre verwendung zur desinfektion von kontaktlinsen und konservierung von pharmazeutischen zubereitungen
DE69431046D1 (de) Rekombinante adenoviren und deren verwendung in der gentherapie zur behandlung von augenerkrankungen
DE69840752D1 (de) Verwendung von coumarine zur behandlung von lebererkrankungen und pankreaserkrankungen
ATE287722T1 (de) Mittel zur behandlung maligner erkrankungen unter verwendung des proteins yb-1
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
DE69534633D1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
PT782630E (pt) Gene da doenca poliquistica do rim
ID23184A (id) Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi
ATE238796T1 (de) Nukleosidderivative in kombinationspräparaten zur behandlung von hsv krankheiten
ATE210126T1 (de) 4-amino-6-substituierte mycophenolsäurederivate mit immunsuppressiver wirkung
ATE165826T1 (de) 4-aminoderivate von 5-substituierten mycophenolsäuren
DE69821227D1 (de) Verwendung von papovavirus kapsid-proteinen zur verabreichung therapeutischen agentien in nervzellen
ATE265526T1 (de) Genetisch veränderte fibroblasten und ihre verwendung
DE69825307D1 (de) Verwendung von protein h als zytostattischer wirkstoff

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties